Clinical Trial Update: AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy

View source ↗

Summary

A clinical trial evaluating an AI-driven liquid biopsy diagnostic system for lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Lung Cancer | Status: COMPLETED